In addition, high DUSP16 expression was found to be associated with poorer disease-free survival in a cohort of HNSCC patients upon completion of chemoradiation therapy (Fig. 7C, D) and in a cohort of breast cancer patients who received platinum-based chemotherapy after surgery (Fig. 7E, F). This evidence concerns the gene DUSP16 and breast cancer.